Setting 
My Cart
Toggle Nav
mobile icon
Close
  • Menu
  • Setting

PLK

PLK (Polo-like kinase 1) is a serine/threonine-protein that are implicated in cell cycle, mitosis, cytokinesis and DNA damage etc.

Items 1-10 of 18

Page
per page
  1. Poloxin
    A3732 Poloxin
    Target: PLK
    Summary: PLK1 inhibitor
      insoluble in H2O; ≥14.85 mg/mL
  2. Rigosertib sodium salt
    A1404 Rigosertib sodium salt
     1 Citation
    Target: PLK
    Summary: Plk1 inhibitor
      ≥23.65 mg/mL
  3. GSK461364
    A8441 GSK461364
     3 Citation
    Target: PLK
    Summary: Plk1 inhibitor
  4. MLN0905
    A8680 MLN0905
    Target: PLK
    Summary: Potent PLK1 inhibitor
      ≥24.35 mg/mL
  5. Ro3280
    A8681 Ro3280
    Target: PLK
    Summary: PLK1 inhibitor,potent and highly selective
      ≥27.2 mg/mL
  6. Rigosertib
    B1288 Rigosertib
    Target: PI3K|PLK
    Summary: PI3K/PLK1 inhibitor
      Soluble in DMSO
  7. SBE 13 HCl
    B5857 SBE 13 HCl
    Target: PLK
    Summary: Inactive Plk1 inhibitor
      Soluble in DMSO
  8. TAK960
    B5860 TAK960
    Target: PLK
    Summary: Oral and selective PLK1 inhibitor
      ≥28.05 mg/mL
  9. 3MB-PP1
    C3340 3MB-PP1
    Summary: polo-like kinase 1 (Plk1) allele inhibitor,ATP-competitive
      ≤2 mg/mL
  10. CFI-400945
    C5813 CFI-400945
    Summary: orally available, selective inhibitor of polo-like kinase 4 (PLK4)
      insoluble in H2O; ≥109.8 mg/mL

Items 1-10 of 18

Page
per page